| Literature DB >> 34974659 |
Yaerim Kim1, Inae Lee2, Jeonghwan Lee3, Jae Yoon Park4, Jung Nam An5, Kyung Don Yoo6, Yong Chul Kim7, Woo Yeong Park1, Kyubok Jin1, Younglim Kho8, Myoungsoon You2, Dong Ki Kim7, Kyungho Choi2, Jung Pyo Lee3.
Abstract
BACKGROUND: The recent novel coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented changes in behavior. We evaluated the current status of precautionary behavior and physical activity in chronic kidney disease (CKD) patients during the COVID-19 pandemic.Entities:
Keywords: COVID-19; Chronic kidney disease; Exercise; Health behavior
Year: 2021 PMID: 34974659 PMCID: PMC8995491 DOI: 10.23876/j.krcp.21.065
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Demographic and clinical characteristics of CKD patients in the SKETCH cohort
| Variable | Total population (n = 306) | Early CKD (n = 119) | Advanced CKD (n = 187) | p-value |
|---|---|---|---|---|
| Age (yr) | 61.0 ± 12.5 | 58.6 ± 13.2 | 62.6 ± 11.8 | 0.007 |
| Male sex | 209 (68.3) | 93 (78.2) | 116 (62.0) | 0.003 |
| Height (cm) | 164.7 ± 9.2 | 166.8 ± 9.5 | 163.3 ± 8.7 | 0.001 |
| Body weight (kg) | 69.5 ± 13.1 | 72.1 ± 13.6 | 67.8 ± 12.6 | 0.005 |
| Body mass index (kg/m2) | 25.6 ± 4.2 | 25.9 ± 4.8 | 25.3 ± 3.7 | 0.22 |
| SBP (mmHg) | 128.1 ± 14.8 | 127.7 ± 13.9 | 128.4 ± 15.3 | 0.71 |
| DBP (mmHg) | 73.3 ± 12.2 | 75.5 ± 10.2 | 72.0 ± 13.2 | 0.008 |
| Diabetes mellitus | 166 (54.2) | 57 (47.9) | 109 (58.3) | 0.08 |
| WBC (×103/μL) | 7.0 ± 1.9 | 6.8 ± 1.8 | 7.1 ± 2.0 | 0.16 |
| Hemoglobin (g/dL) | 12.6 ± 2.0 | 13.9 ± 1.6 | 11.8 ± 1.8 | <0.001 |
| Platelets (×103/μL) | 223.0 ± 62.6 | 234.3 ± 58.4 | 215.9 ± 64.2 | 0.01 |
| Glucose (mg/dL) | 120.1 ± 44.0 | 118.4 ± 36.6 | 121.1 ± 48.2 | 0.58 |
| Total cholesterol (mg/dL) | 158.3 ± 53.7 | 159.4 ± 40.4 | 157.5 ± 60.9 | 0.77 |
| Protein (g/dL) | 7.0 ± 0.5 | 7.1 ± 0.6 | 6.9 ± 0.5 | 0.02 |
| Albumin (g/dL) | 4.3 ± 0.4 | 4.5 ± 0.4 | 4.3 ± 0.4 | <0.001 |
| Bilirubin (mg/dL) | 0.5 ± 0.3 | 0.6 ± 0.3 | 0.5 ± 0.3 | <0.001 |
| Uric acid (mg/dL) | 6.5 ± 1.8 | 6.3 ± 1.7 | 6.6 ± 1.8 | 0.20 |
| BUN (mg/dL) | 28.8 ± 12.8 | 20.1 ± 6.5 | 34.3 ± 12.7 | <0.001 |
| Creatinine (mg/dL) | 1.8 ± 0.7 | 1.2 ± 0.3 | 2.2 ± 0.6 | <0.001 |
| GFR (CKD-EPI) (mL/min/1.73 m2) | 43.2 ± 20.7 | 63.2 ± 18.4 | 30.4 ± 8.1 | <0.001 |
| uPCR (g/gCr) | 0.9 ± 1.3 | 0.5 ± 0.8 | 1.1 ± 1.6 | <0.001 |
Data are expressed as mean ± standard deviation or number (%).
SKETCH cohort, the Study on Kidney Disease and Environmental Chemicals (Clinical Trial No. NCT04679168).
BUN, blood urea nitrogen; CKD, chronic kidney disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration equation; DBP, diastolic blood pressure; GFR, glomerular filtration rate; SBP, systolic blood pressure; uPCR, urine protein creatinine ratio; WBC, white blood cells.
Figure 1.Distribution of enrolled participants and risk cognition according to the pandemic.
(A) Number of participating chronic kidney disease patients recruited in the Study on Kidney Disease and Environmental Chemicals (SKETCH, Clinical Trial No. NCT04679168) cohort in comparison with the daily number of confirmed cases of coronavirus disease 2019 (COVID-19) nationwide (left Y-axis and red line). The proportion of people who answered ‘serious’ or ‘very serious’ for the possibility of infection by COVID-19 in the general populations is shown by the blue dotted line (right Y-axis). (B) Comparison of risk perception between the general population of Korea (n = 1,000, left) and those who were participating in the SKETCH cohort (right) for given periods. Specific time periods were demonstrated under the graph, and “*” represented the period for chronic kidney disease (CKD) patients. Crimson red, gray, and blue colors indicate the proportion of the population who answered ‘high’ (‘4’ or ‘5’), ‘moderate’ (‘3’), and ‘low’ (‘1’ or ‘2’) levels of risk perception, respectively.
*The statistics for the incidence of COVID-19 represented with a black line were obtained from the Korean Statistical Information Service. The risk perception for COVID-19 in the general population was obtained from Hankook Research (https://hrcopinion.co.kr/covid-19, accessed December 18, 2020), which collected data from 1,000 subjects through biweekly survey events.
Perceived risk of COVID-19 infection by demographic and socioeconomic characteristics, and CKD stage
| Variable | Total (n = 306) | |
|---|---|---|
| OR (95% CI) | p-value | |
| Age (yr) (Ref, <50) | ||
| 50s | 1.49 (0.69–3.20) | 0.31 |
| 60s | 3.26 (1.59–6.67) | 0.001* |
| ≥70 | 3.92 (1.89–8.15) | <0.001[ |
| Sex (Ref, male) | ||
| Female | 1.06 (0.65–1.72) | 0.82 |
| Education[ | ||
| Middle school | 0.62 (0.29–1.35) | 0.23 |
| High school | 0.44 (0.23–0.85) | 0.01[ |
| ≥College | 0.32 (0.16–0.64) | 0.001[ |
| Income[ | ||
| 1,000–2,000 | 1.21 (0.62–2.36) | 0.58 |
| 2,000–3,000 | 0.89 (0.42–1.87) | 0.75 |
| 3,000–5,000 | 0.44 (0.23–0.87) | 0.02[ |
| ≥5,000 | 0.27 (0.13–0.55) | <0.001[ |
| CCI (Ref, <4) | ||
| ≥4 | 1.66 (1.05–2.62) | 0.03[ |
| Diabetes | 1.35 (0.86–2.12) | 0.20 |
| CKD stage (Ref, early CKD) | ||
| Advanced CKD | 1.46 (0.91–2.33) | 0.11 |
CCI, Charlson comorbidity index; CI, confidence interval; Ref, reference; CKD, chronic kidney disease; COVID-19, coronavirus disease 2019; OR, odds ratio.
n = 305 (total) and n = 176 (≥60 years).
p < 0.05.
Behavioral changes related to social distancing, hygiene, and exercise during COVID-19 pandemic compared with before the pandemic
| Factor | Category | No | Before | After | % increase | % decrease |
|---|---|---|---|---|---|---|
| Social distancing | Public places (time/wk) | 306 | 2.3 ± 2.7 | 1.1 ± 2.2[ | 1.6 | 42.8 |
| Public transport (time/wk) | 306 | 1.9 ± 3.2 | 1.4 ± 3.1[ | 2.6 | 17.0 | |
| Personal transport (time/wk) | 304 | 1.1 ± 2.0 | 1.1 ± 2.0 | 6.9 | 5.3 | |
| Stay-at-home (hr/day) | 306 | 12.0 ± 5.7 | 13.5 ± 5.7[ | 34.0 | 1.6 | |
| Hygiene | Mask (time/wk) | 306 | 1.0 ± 2.2 | 6.2 ± 1.7[ | 85.0 | 0.3 |
| Hand sanitizer (time/wk) | 306 | 1.4 ± 4.9 | 8.4 ± 9.4[ | 87.3 | 0.3 | |
| Clothes (time before laundry) | 306 | 1.9 ± 1.1 | 2.0 ± 1.4 | 15.0 | 11.1 | |
| Laundry (time/wk) | 306 | 3.3 ± 2.1 | 3.7 ± 2.1[ | 23.5 | 0.7 | |
| Cleaning the house (time/wk) | 306 | 4.6 ± 2.5 | 5.0 ± 2.6[ | 22.5 | 1.3 | |
| Soap (time/day) | 306 | 3.3 ± 3.6 | 6.1 ± 5.0[ | 80.4 | 1.3 | |
| Shower (time/day) | 306 | 1.1 ± 0.7 | 1.3 ± 0.8[ | 19.9 | 0.3 | |
| Exercise | Total exercise (time/wk) | 306 | 2.7 ± 2.8 | 2.5 ± 2.7 | 12.4 | 14.7 |
| Irregular exercise (time/wk) | 128 | 0.7 ± 1.3 | 0.9 ± 1.5 | 15.6 | 7.0 | |
| Regular exercise (time/wk) | 178 | 4.1 ± 2.7 | 3.7 ± 2.8[ | 10.1 | 20.2 | |
| Exercise at gym (time/wk) | 28 | 3.6 ± 1.9 | 2.5 ± 2.1[ | 14.3 | 42.9 | |
| Without diabetes (time/wk) | 140 | 2.4 ± 2.4 | 2.1 ± 2.3[ | 9.3 | 17.1 | |
| With diabetes (time/wk) | 166 | 2.9 ± 3.1 | 2.9 ± 3.0 | 15.1 | 12.7 | |
| CCI < 4 (time/wk) | 142 | 2.4 ± 2.4 | 2.0 ± 2.2[ | 9.2 | 19.0 | |
| CCI ≥ 4 (time/wk) | 164 | 3.0 ± 3.1 | 3.0 ± 3.0 | 14.0 | 9.8 | |
| Early CKD (time/wk) | 116 | 2.6 ± 2.6 | 2.4 ± 2.4 | 13.8 | 18.1 | |
| Advanced CKD (time/wk) | 190 | 2.7 ± 2.9 | 2.6 ± 2.9 | 11.6 | 12.6 |
Data are expressed as number only, mean ± standard deviation, or percentage only.
CCI, Charlson comorbidity index; CKD, chronic kidney disease; COVID-19, coronavirus disease 2019.
Wilcoxon signed-rank test was conducted;
p < 0.05,
p < 0.01,
p < 0.001.
Behavioral changes related to social distancing by demographic and socioeconomic characteristics and comorbidities after age adjustment
| Variable | Frequency | |||||||
|---|---|---|---|---|---|---|---|---|
| Using public transport (decreased) | Using private vehicle (increased) | Visiting public place (decreased) | Hour of stay-at-home (increased) | |||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Sex[ | ||||||||
| Female | 1.68 (0.90–3.14) | 0.12 | 1.01 (0.39–2.60) | 0.99 | 1.39 (0.85–2.28) | 0.19 | 1.68 (1.01–2.78) | 0.046[ |
| Education[ | ||||||||
| Middle school | 0.76 (0.28–2.09) | 0.60 | 2.55 (0.44–14.94) | 0.30 | 0.56 (0.24–1.28) | 0.17 | 0.80 (0.35–1.84) | 0.61 |
| High school | 0.94 (0.39–2.26) | 0.88 | 3.13 (0.61–16.01) | 0.17 | 0.98 (0.48–1.99) | 0.95 | 1.01 (0.49–2.11) | 0.98 |
| ≥College | 0.94 (0.36–2.47) | 0.90 | 0.80 (0.11–5.57) | 0.82 | 1.67 (0.78–3.59) | 0.19 | 1.17 (0.53–2.57) | 0.70 |
| Income[ | ||||||||
| 1,000–2,000 | 1.40 (0.61–3.20) | 0.43 | 0.45 (0.09–2.33) | 0.34 | 1.47 (0.73–2.94) | 0.28 | 3.04 (1.46–6.35) | 0.003[ |
| 2,000–3,000 | 0.96 (0.33–2.82) | 0.95 | 1.02 (0.22–4.76) | 0.98 | 1.69 (0.75–3.79) | 0.21 | 2.56 (1.08–6.08) | 0.03[ |
| 3,000–5,000 | 1.02 (0.37–2.82) | 0.98 | 1.74 (0.45–6.65) | 0.42 | 1.60 (0.74–3.47) | 0.23 | 2.30 (1.00–5.33) | 0.05 |
| ≥5,000 | 0.68 (0.22–2.13) | 0.51 | 0.16 (0.02–1.60) | 0.12 | 2.04 (0.92–4.50) | 0.08 | 3.10 (1.32–7.25) | 0.009[ |
| Risk perception (Ref, <3) | ||||||||
| ≥4 | 1.91 (1.01–3.60) | 0.046* | 0.96 (0.38–2.42) | 0.92 | 1.40 (0.87–2.26) | 0.17 | 1.39 (0.85–2.29) | 0.19 |
| CCI (Ref, <4) | ||||||||
| ≥4 | 0.96 (0.52–1.79) | 0.90 | 1.28 (0.51–3.21) | 0.60 | 0.82 (0.52–1.32) | 0.42 | 0.68 (0.42–1.10) | 0.12 |
| Diabetes | 0.64 (0.35–1.19) | 0.16 | 1.49 (0.59–3.78) | 0.40 | 0.66 (0.41–1.05) | 0.08 | 0.70 (0.43–1.13) | 0.15 |
| CKD stage[ | ||||||||
| Advanced CKD | 1.62 (0.83–3.15) | 0.16 | 1.56 (0.58–4.19) | 0.38 | 0.80 (0.50–1.28) | 0.35 | 0.54 (0.33–0.88) | 0.01[ |
CCI, Charlson comorbidity index; CI, confidence interval; CKD, chronic kidney disease; OR, odds ratio; Ref, reference.
n = 304 (personal transport);
n = 303 (personal transport).
p < 0.05.
Behavioral changes related to hygiene by demographic and socioeconomic characteristics and comorbidities after age adjustment
| Variable | Frequency | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Handwashing (increased) | Shower (increased) | Face mask (increased) | Hand sanitizer (increased) | No. of clothes use before laundry (decreased) | Laundry (increased) | Home cleaning (increased) | ||||||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Sex (Ref, male) | ||||||||||||||
| Female | 0.97 (0.53–1.79) | 0.93 | 1.32 (0.73–2.39) | 0.36 | 1.61 (0.78–3.34) | 0.20 | 1.09 (0.52–2.26) | 0.82 | 1.68 (0.80–3.52) | 0.17 | 1.65 (0.95–2.86) | 0.08 | 1.19 (0.67–2.12) | 0.55 |
| Education (Ref, ≤elementary school) | ||||||||||||||
| Middle school | 0.72 (0.29–1.82) | 0.49 | 1.10 (0.43–2.86) | 0.84 | 0.66 (0.25–1.76) | 0.41 | 0.88 (0.32–2.37) | 0.79 | 0.57 (0.13–2.58) | 0.47 | 0.86 (0.33–2.24) | 0.76 | 1.02 (0.38–2.74) | 0.97 |
| High school | 0.96 (0.40–2.32) | 0.93 | 1.00 (0.42–2.38) | >0.99 | 2.01 (0.72–5.64) | 0.18 | 3.45 (1.14–10.45) | 0.03[ | 0.96 (0.29–3.16) | 0.95 | 1.16 (0.51–2.65) | 0.73 | 1.12 (0.46–2.70) | 0.80 |
| ≥College | 1.01 (0.39–2.63) | 0.99 | 0.79 (0.30–2.06) | 0.63 | 1.37 (0.48–3.96) | 0.56 | 2.10 (0.70–6.36) | 0.188 | 1.36 (0.40–4.63) | 0.62 | 1.01 (0.41–2.48) | 0.98 | 1.03 (0.40–2.64) | 0.95 |
| Income (Ref, <$1,000) | ||||||||||||||
| 1,000–2,000 | 1.54 (0.65–3.70) | 0.33 | 1.13 (0.50–2.56) | 0.78 | 0.95 (0.38–2.41) | 0.92 | 1.78 (0.66–4.76) | 0.25 | 1.30 (0.33–5.18) | 0.71 | 1.07 (0.48–2.41) | 0.86 | 2.03 (0.87–4.75) | 0.10 |
| 2,000–3,000 | 0.99 (0.39–2.53) | 0.98 | 0.74 (0.27–2.06) | 0.57 | 0.89 (0.31–2.56) | 0.83 | 1.48 (0.49–4.46) | 0.48 | 4.38 (1.22–15.71) | 0.02[ | 1.02 (0.40–2.62) | 0.97 | 2.53 (0.99–6.48) | 0.05 |
| 3,000–5,000 | 1.49 (0.56–3.93) | 0.42 | 0.94 (0.37–2.37) | 0.90 | 1.24 (0.43–3.58) | 0.70 | 4.38 (1.21–15.88) | 0.03[ | 2.14 (0.55–8.31) | 0.27 | 0.77 (0.30–1.95) | 0.58 | 1.41 (0.55–3.63) | 0.48 |
| ≥5,000 | 1.21 (0.45–3.22) | 0.71 | 0.53 (0.19–1.47) | 0.23 | 1.48 (0.48–4.54) | 0.49 | 3.76 (1.10–12.91) | 0.04[ | 3.26 (0.87–12.18) | 0.08 | 1.46 (0.60–3.53) | 0.40 | 1.32 (0.50–3.48) | 0.57 |
| Risk perception (Ref, <3) | ||||||||||||||
| ≥4 | 0.86 (0.48–1.55) | 0.62 | 1.04 (0.58–1.87) | 0.9 | 0.90 (0.47–1.73) | 0.76 | 1.10 (0.55–2.23) | 0.78 | 0.53 (0.24–1.18) | 0.12 | 1.47 (0.85–2.56) | 0.17 | 0.89 (0.51–1.57) | 0.69 |
| CCI (Ref, <4) | ||||||||||||||
| ≥4 | 0.58 (0.32–1.07) | 0.08 | 0.94 (0.53–1.67) | 0.83 | 0.64 (0.33–1.23) | 0.18 | 0.33 (0.15–0.72) | 0.006[ | 0.64 (0.30–1.34) | 0.23 | 0.63 (0.36–1.08) | 0.09 | 0.75 (0.43–1.31) | 0.31 |
| Diabetes | 0.71 (0.40–1.28) | 0.26 | 0.89 (0.50–1.58) | 0.69 | 1.02 (0.54–1.94) | 0.95 | 0.47 (0.23–0.99) | 0.046[ | 0.46 (0.21–0.97) | 0.04[ | 0.70 (0.41–1.20) | 0.20 | 0.90 (0.52–1.56) | 0.70 |
| CKD stage (Ref, early CKD) | ||||||||||||||
| Advanced CKD | 0.65 (0.35–1.20) | 0.166 | 0.52 (0.29–0.93) | 0.03[ | 0.77 (0.39–1.51) | 0.45 | 0.72 (0.34–1.49) | 0.37 | 0.55 (0.26–1.13) | 0.10 | 0.82 (0.48–1.42) | 0.49 | 0.72 (0.41–1.25) | 0.24 |
CCI, Charlson comorbidity index; CI, confidence interval; CKD, chronic kidney disease; OR, odds ratio; Ref, reference.
p < 0.05.
Behavioral changes related to exercise by demographic and socioeconomic characteristics and comorbidities after age adjustment
| Variable | Increased frequency | |||||
|---|---|---|---|---|---|---|
| Overall | Irregular exercise (n = 128) | Regular exercise (n = 178) | ||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Sex (Ref, male) | ||||||
| Female | 0.63 (0.29–1.40) | 0.26 | 0.65 (0.22–1.93) | 0.44 | 0.66 (0.20–2.16) | 0.496 |
| Education (Ref, ≤middle school) | ||||||
| ≥High school | 1.51 (0.62–3.66) | 0.37 | 0.88 (0.29–2.67) | 0.82 | 3.41 (0.66–17.73) | 0.15 |
| Income (Ref, <$2,000) | ||||||
| ≥$2,000 | 1.72 (0.77–3.85) | 0.19 | 0.78 (0.27–2.28) | 0.65 | 4.76 (1.18–19.21) | 0.03[ |
| Risk perception (Ref, <3) | ||||||
| ≥4 | 0.58 (0.27–1.21) | 0.15 | 1.01 (0.37–2.75) | 0.99 | 0.32 (0.10–1.05) | 0.06 |
| CCI (Ref, <4) | ||||||
| ≥4 | 2.10 (1.01–4.38) | 0.048[ | 3.31 (1.09–10.00) | 0.03[ | 1.35 (0.49–3.75) | 0.56 |
| Diabetes | 1.96 (0.95–4.06) | 0.07 | 2.61 (0.92–7.38) | 0.07 | 1.51 (0.54–4.25) | 0.43 |
| CKD stage | ||||||
| Advanced CKD | 0.87 (0.43–1.74) | 0.69 | 1.30 (0.47–3.57) | 0.61 | 0.53 (0.19–1.43) | 0.21 |
Due to no observations for explanatory variable (frequency of exercise) in some age, education, household income groups, the groups were redefined.
CCI, Charlson comorbidity index; CI, confidence interval; CKD, chronic kidney disease; OR, odds ratio; Ref, reference.
p < 0.05.